Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, Conference Calls/ Webcasts

Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit


VANCOUVER, British Columbia, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at Jefferies Inaugural Biotech CNS/Neuro Summit to be held on October 11, 2023.

Company Fireside Chat Presentation Details:

Date:Wednesday, October 11, 2023
  
Time:2:25 PM Eastern Time
  
Webcast:Register here
  
Presenters:Ian Mortimer, President and Chief Executive Officer
Sherry Aulin, Chief Financial Officer
  

A live webcast of the company presentation will be available on the "Investors" section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

"Xenon" and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: (604) 484-3353
Email: [email protected]



These press releases may also interest you

at 18:44
RXNT Announces Transition to Relay Exchange Clearinghouse
Healthcare technology company RXNT, a leading developer of ambulatory clinical and practice management software, announced its successful transition to the Relay Exchange clearinghouse via Change Healthcare on May 9th, 2024. This...

at 18:32
Center for Lyme Action and Generation Lyme Create Community Partnership to Empower Lyme and Tick-borne Disease Advocates
Center for Lyme Action (CLA) and Generation Lyme are pleased to announce a new Community Partnership to leverage each nonprofit organization's distinct resources to support current and future Lyme disease advocates. This collaboration marks a...

at 18:18
LG ELECTRONICS ANNOUNCES THIRD SEASON OF MENTAL HEALTH AWARENESS PODCAST 'TRANSPARENT CONVERSATIONS'
LG Electronics announces the launch of the third season of its podcast, "Transparent Conversations," which brings conversations about mental health directly to college campuses around the country, with live tapings throughout the year at pivotal...

at 18:15
DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference
DaVita Inc.  today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at BofA Securities 2024 Health Care Conference on...

at 17:36
Statement from DentaQuest President Steve Pollock on Newly Funded Medicaid Adult Dental Benefit in Georgia
Georgia lawmakers recently approved approximately $11 million to support an adult dental benefit for people enrolled in Medicaid. This is the first step toward helping low-income adults with Medicaid coverage obtain routine oral health care. Prior to...

at 17:35
VitalHub Corp. Reports First Quarter 2024 Financial Results
VitalHub Corp. (the "Company" or "VitalHub") announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis report for the three ended March 31, 2024, with the Canadian securities...

More news about Health...


News published on and distributed by: